- Home
- MODD vs BNR Comparison
MODD vs BNR Comparison
Compare MODD & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODD
- BNR
- Stock Information
- Founded
- MODD 1998
- BNR 2014
- Country
- MODD United States
- BNR China
- Employees
- MODD N/A
- BNR N/A
- Industry
- MODD Industrial Specialties
- BNR Medical Specialities
- Sector
- MODD Health Care
- BNR Health Care
- Exchange
- MODD Nasdaq
- BNR Nasdaq
- Market Cap
- MODD 46.3M
- BNR 38.3M
- IPO Year
- MODD N/A
- BNR 2020
- Fundamental
- Price
- MODD $0.71
- BNR $9.48
- Analyst Decision
- MODD
- BNR
- Analyst Count
- MODD 0
- BNR 0
- Target Price
- MODD N/A
- BNR N/A
- AVG Volume (30 Days)
- MODD 55.0K
- BNR 48.9K
- Earning Date
- MODD 08-14-2025
- BNR 09-08-2025
- Dividend Yield
- MODD N/A
- BNR N/A
- EPS Growth
- MODD N/A
- BNR N/A
- EPS
- MODD N/A
- BNR N/A
- Revenue
- MODD N/A
- BNR $74,862,782.00
- Revenue This Year
- MODD N/A
- BNR $136.32
- Revenue Next Year
- MODD N/A
- BNR N/A
- P/E Ratio
- MODD N/A
- BNR N/A
- Revenue Growth
- MODD N/A
- BNR 5.20
- 52 Week Low
- MODD $0.63
- BNR $2.18
- 52 Week High
- MODD $2.50
- BNR $11.12
- Technical
- Relative Strength Index (RSI)
- MODD 46.14
- BNR 62.81
- Support Level
- MODD $0.69
- BNR $7.83
- Resistance Level
- MODD $0.75
- BNR $9.10
- Average True Range (ATR)
- MODD 0.04
- BNR 0.76
- MACD
- MODD -0.00
- BNR -0.08
- Stochastic Oscillator
- MODD 22.76
- BNR 77.39
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.